SEC Company Response from GeoVax Labs, Inc. (GOVX) (CIK 0000832489) (GOVX) — Apr 4, 2016
GeoVax Labs, Inc. (GOVX) (CIK 0000832489)
Date: April 4, 2016 · CIK: 0000832489 · Accession: 0001437749-16-029029
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-202897, 333-206617, 333-208549
Referenced dates: March 31, 2016
Letter
govx20160404_corresp.htm
T. CLARK FITZGERALD III
Partner
Direct Dial: (404) 879-2455 Direct Fax: (404) 870-4869
E-mail: CFitzgerald@wcsr.com
April 4, 2016
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 3561
100 F Street, NE
Washington, D.C. 20549
Attention: John Reynolds
Assistant Director
RE: GeoVax Labs, Inc.
Post-Effective Amendments to Forms S-1
Filed March 16, 2016
File Nos. 333-202897, 333-206617, and 333-208549
Ladies and Gentlemen:
On behalf of GeoVax Labs, Inc., a Delaware corporation (the “Company”), this letter responds to the comments received from the staff of the Securities and Exchange Commission (the “Commission”) in a letter dated March 31, 2016 with respect to the post-effective amendments referenced above (collectively, the “Post-Effective Amendments”).
A courtesy copy of this letter is being provided directly to the staff for its convenience (attention: Kathleen Suellentrop).
To facilitate the staff’s review, the Commission’s comments are provided before each of the Company’s responses thereto.
General
We note your disclosure in each of your post-effective amendments that you wish to use Rule 429 to combine the prospectuses in the registration statements with the file numbers 333-202897, 333-206617, and 333-208549. Under Rule 429, you may file a combined prospectus in the latest registration statement and this registration statement will act, upon effectiveness, as a post-effective amendment to the earlier registrations statements whose prospectuses have been combined in the latest registration statement. Therefore, please withdraw the post-effective amendments under file numbers 333-202897 and 333-206617 or advise.
U.S. Securities and Exchange Commission
April 4, 2016
Page 2
Response: As requested by the staff, the Company has requested the withdrawal of the post-effective amendments with file numbers of 333-206617 and 333-202897 through the filing with the Commission of Form AWs on April 4, 2016.
Should any member of SEC’s staff have any questions, or desire any further information or clarification in respect of the Post-Effective Amendments, please do not hesitate to contact me at (404) 879-2455 or the Company’s Chief Financial Officer, Mark Reynolds, at (678) 384-7224.
Sincerely,
WOMBLE CARLYLE SANDRIDGE & RICE
Show Raw Text
CORRESP 1 filename1.htm govx20160404_corresp.htm T. CLARK FITZGERALD III Partner Direct Dial: (404) 879-2455 Direct Fax: (404) 870-4869 E-mail: CFitzgerald@wcsr.com April 4, 2016 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Mail Stop 3561 100 F Street, NE Washington, D.C. 20549 Attention: John Reynolds Assistant Director RE: GeoVax Labs, Inc. Post-Effective Amendments to Forms S-1 Filed March 16, 2016 File Nos. 333-202897, 333-206617, and 333-208549 Ladies and Gentlemen: On behalf of GeoVax Labs, Inc., a Delaware corporation (the “Company”), this letter responds to the comments received from the staff of the Securities and Exchange Commission (the “Commission”) in a letter dated March 31, 2016 with respect to the post-effective amendments referenced above (collectively, the “Post-Effective Amendments”). A courtesy copy of this letter is being provided directly to the staff for its convenience (attention: Kathleen Suellentrop). To facilitate the staff’s review, the Commission’s comments are provided before each of the Company’s responses thereto. General We note your disclosure in each of your post-effective amendments that you wish to use Rule 429 to combine the prospectuses in the registration statements with the file numbers 333-202897, 333-206617, and 333-208549. Under Rule 429, you may file a combined prospectus in the latest registration statement and this registration statement will act, upon effectiveness, as a post-effective amendment to the earlier registrations statements whose prospectuses have been combined in the latest registration statement. Therefore, please withdraw the post-effective amendments under file numbers 333-202897 and 333-206617 or advise. U.S. Securities and Exchange Commission April 4, 2016 Page 2 Response: As requested by the staff, the Company has requested the withdrawal of the post-effective amendments with file numbers of 333-206617 and 333-202897 through the filing with the Commission of Form AWs on April 4, 2016. Should any member of SEC’s staff have any questions, or desire any further information or clarification in respect of the Post-Effective Amendments, please do not hesitate to contact me at (404) 879-2455 or the Company’s Chief Financial Officer, Mark Reynolds, at (678) 384-7224. Sincerely, WOMBLE CARLYLE SANDRIDGE & RICE A Limited Liability Partnership /s/ T. Clark Fitzgerald III T. Clark Fitzgerald III TCF/cd